Stocks and Investing
Stocks and Investing
Fri, June 24, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 23, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Butler Downgraded (ATHA) to Hold on, Jun 23rd, 2022
Jason Butler of JMP Securities, Downgraded "Athira Pharma, Inc." (ATHA) to Hold on, Jun 23rd, 2022.
Jason has made no other calls on ATHA in the last 4 months.
There are 2 other peers that have a rating on ATHA. Out of the 2 peers that are also analyzing ATHA, 0 agree with Jason's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jason
- Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
- Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022
Contributing Sources